Clinical trial
Effects of Angiotensin Converting Enzyme Inhibitors on Peritoneal Protein Loss and Solute Transport in Peritoneal Dialysis Patients
NCT01575652 is registered in ClinicalTrials.gov with Turkish Nephrology Association as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Angiotensin Converting Enzyme Inhibitors on Peritoneal Protein Loss and Solute Transport in Peritoneal Dialysis Patients
- Lead sponsor
- Turkish Nephrology Association
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- January 31, 2009
- Enrollment
- 43 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
disorders associated with peritoneal dialysis